CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 32 filers reported holding CASI PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $187,000 | +94.8% | 22,935 | 0.0% | 0.02% | +92.3% |
Q1 2018 | $96,000 | +17.1% | 22,935 | -7.0% | 0.01% | +18.2% |
Q4 2017 | $82,000 | +70.8% | 24,663 | -5.3% | 0.01% | +57.1% |
Q3 2017 | $48,000 | +77.8% | 26,053 | 0.0% | 0.01% | +75.0% |
Q2 2017 | $27,000 | -28.9% | 26,053 | 0.0% | 0.00% | -33.3% |
Q1 2017 | $38,000 | -58.7% | 26,053 | -67.2% | 0.01% | -60.0% |
Q4 2016 | $92,000 | -1.1% | 79,486 | -5.5% | 0.02% | -6.2% |
Q3 2016 | $93,000 | -8.8% | 84,148 | -0.5% | 0.02% | -11.1% |
Q2 2016 | $102,000 | +22.9% | 84,609 | +7.8% | 0.02% | +20.0% |
Q1 2016 | $83,000 | +40.7% | 78,456 | +21.7% | 0.02% | +36.4% |
Q4 2015 | $59,000 | -32.2% | 64,476 | -21.8% | 0.01% | -31.2% |
Q3 2015 | $87,000 | -46.3% | 82,402 | -6.5% | 0.02% | -38.5% |
Q2 2015 | $162,000 | +25.6% | 88,155 | -2.3% | 0.03% | +18.2% |
Q1 2015 | $129,000 | -2.3% | 90,214 | -8.9% | 0.02% | 0.0% |
Q4 2014 | $132,000 | -24.6% | 98,996 | +3.4% | 0.02% | -26.7% |
Q3 2014 | $175,000 | – | 95,696 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
Aristides Capital LLC | 63,250 | $152,000 | 0.06% |